1. Home
  2. MBRX vs WVVI Comparison

MBRX vs WVVI Comparison

Compare MBRX & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$3.37

Market Cap

13.1M

Sector

Health Care

ML Signal

HOLD

Logo Willamette Valley Vineyards Inc.

WVVI

Willamette Valley Vineyards Inc.

N/A

Current Price

$2.22

Market Cap

13.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
MBRX
WVVI
Founded
2015
1983
Country
United States
United States
Employees
N/A
299
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
13.1M
13.7M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
MBRX
WVVI
Price
$3.37
$2.22
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$61.00
N/A
AVG Volume (30 Days)
327.0K
3.5K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$2.16
52 Week High
$7.98
$5.89

Technical Indicators

Market Signals
Indicator
MBRX
WVVI
Relative Strength Index (RSI) 69.78 27.99
Support Level $3.13 N/A
Resistance Level $5.22 $2.84
Average True Range (ATR) 0.23 0.14
MACD 0.06 -0.05
Stochastic Oscillator 87.60 6.24

Price Performance

Historical Comparison
MBRX
WVVI

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

Share on Social Networks: